Re: News Releases - Friday, April 03, 2009
BacTech Closes First and Second Tranches of Private Placement
====================================...
Toronto, Canada, April 3, 2009 - BacTech Mining Corporation ("BacTech"
or the "Company", TSX.V: BM) today announced that it has closed the
first and second tranches of its non-brokered private placement
announced March 16, 2009, for total gross proceeds of $495,000. This
has allowed the Company to repurchase its $3 million debenture
commitment for $400,000 (see news release of March 16, 2009). A third
closing is anticipated next week for the balance of the $750,000
financing which is oversubscribed.
The terms of the private placement are as follows: unit price $0.04,
with a unit comprised of one common share and one two-year common share
purchase warrant. Each warrant entitles the holder to acquire one
common share at a price of $0.07 per share during the first year of the
two year exercise period, and at a price of $0.10 per share during the
second year.
All securities issued for the first tranche of the offering, and the
underlying securities, are subject to a four-month hold period that
expires August 1, 2009, with the two-year warrants expiring March 31,
2011. All securities issued for the second tranche of the offering,
and the underlying securities, are subject to a four-month hold period
that expires August 3, 2009, with the two-year warrants expiring April
2, 2011.
In connection with the offering, and subject to approval by the TSX
Venture Exchange, BacTech will pay to certain arm's length parties a
finder's fee in the amount of 8% of the gross proceeds raised. The
finder's fee is payable in cash, shares, or a combination of both.
BACTECH PROFILE
BacTech owns patented bacterial oxidation technology for the treatment
of refractory ores and concentrates to enhance the recovery of gold,
silver and base metals. The Company's focus is the acquisition of
equity positions in projects amenable to bioleaching. In June 2008, the
Company signed an agreement to acquire Yamana Gold Inc.'s 33% interest
in two refractory gold deposits in Papua New Guinea. In September 2008,
BacTech signed an MOU to investigate the use of bioleaching to
reprocess arsenic-laden tailings in Cobalt, Ontario. This is the
Company's first foray into the cleantech industry. BacTech is
continuing to evaluate additional remediation projects.
- 30 -
For further information contact:
Ross Orr, President & CEO, 416-813-0303 ext 222
Investor Relations:
Pierre Anglos 1-800-436-2027 Email: mailto:capitalgainsco@shaw.ca
Shares outstanding 73,482,206
